INFORMATION ABOUT COMPONENTS OF EQUITY - Reverse recapitalization (Details)
|
Mar. 14, 2019
USD ($)
|
Feb. 27, 2019
USD ($)
$ / shares
shares
|
Mar. 02, 2018
$ / shares
shares
|
Jun. 30, 2020
shares
|
Dec. 31, 2017
shares
|
| INFORMATION ABOUT COMPONENTS OF EQUITY |
|
|
|
|
|
| Excess of fair value of equity instruments over the net monetary assets acquired | $ |
$ 20,900,000
|
|
|
|
|
| Trust account proceeds incorporated to the Group | $ |
|
$ 1,083,840
|
|
|
|
| Bioceres LLC |
|
|
|
|
|
| INFORMATION ABOUT COMPONENTS OF EQUITY |
|
|
|
|
|
| Number of instruments or interests issued or issuable | $ |
27,116,174
|
|
|
|
|
| Public warrants |
|
|
|
|
|
| INFORMATION ABOUT COMPONENTS OF EQUITY |
|
|
|
|
|
| Number of shares issued |
|
|
|
11,500,000
|
|
| Warrants exercise price (USD per share) | $ / shares |
|
|
$ 11.50
|
|
|
| UAC |
|
|
|
|
|
| INFORMATION ABOUT COMPONENTS OF EQUITY |
|
|
|
|
|
| Number of units sold in IPO |
|
|
11,500,000
|
|
|
| Number of ordinary share in a unit sold in IPO |
|
|
1
|
|
|
| Number of exchange right ordinary share in a unit sold in IPO |
|
|
1
|
|
|
| Exchange ratio of exchange right ordinary share in a unit sold in IPO |
|
|
0.10
|
|
|
| Number of warrants in a unit sold in IPO |
|
|
1
|
|
|
| Number shares the warrants can be exercise to |
|
|
1
|
|
|
| Number of rights converted to ordinary shares |
|
11,500,000
|
|
|
|
| Number of shares issued for the 11,500,000 rights |
|
1,150,000
|
|
|
|
| Number ordinary share redeemed |
|
11,376,836
|
|
|
|
| Redemption payment | $ |
|
$ 117,005,196
|
|
|
|
| Share price | $ / shares |
|
$ 5.35
|
|
|
|
| UAC | Founder Shares |
|
|
|
|
|
| INFORMATION ABOUT COMPONENTS OF EQUITY |
|
|
|
|
|
| Number of shares issued |
|
|
|
|
2,875,000
|
| Original founders of Union | Founder Shares | Bioceres LLC |
|
|
|
|
|
| INFORMATION ABOUT COMPONENTS OF EQUITY |
|
|
|
|
|
| Number of instruments or interests issued or issuable | $ |
862,500
|
|
|
|
|